Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 10/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 8/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.36 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18503605 | 0.92 | ALDH1A1 (0.40) | ALDH1A1P2RX7CHRM3TP53LMNA | |
| SCHEMBL18503590 | 0.91 | ALDH1A1 (0.40) | ALDH1A1P2RX7CHRM3TP53LMNA | |
| SCHEMBL18503598 | 0.90 | CYP11B2 (0.49) | CYP11B2CYP11B1CHRM3TP53LMNA | |
| SCHEMBL18503629 | 0.88 | LMNA (0.41) | CYP11B2CYP11B1CHRM3TP53LMNA | |
| SCHEMBL19566549 | 0.88 | P2RX7 (0.47) | P2RX7CHRM3TP53LMNAGAA | |
| SCHEMBL18503638 | 0.87 | HDAC6 (0.41) | CYP11B2CYP11B1ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL18503634 | 0.86 | LMNA (0.40) | CYP11B2ALDH1A1P2RX7CHRM3TP53 | |
| SCHEMBL18503604 | 0.86 | CYP11B2 (0.44) | CYP11B2CYP11B1CHRM3TP53LMNA | |
| SCHEMBL18503596 | 0.86 | CYP11B2 (0.60) | CYP11B2CYP11B1TP53HCRTR1HCRTR2 | |
| SCHEMBL18503606 | 0.85 | KCNQ3 (0.45) | CYP11B2CYP11B1ALDH1A1P2RX7CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | BAYER ANIMAL HEALTH GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | BAYER ANIMAL HEALTH GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | ACHE, DDT, DNPH1 | CYP11B2 2963/4885CYP11B1 3138/4885ALDH1A1 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.